TMates vs Strut Health 2026: Which Compounded GLP-1 Provider Wins?
Updated May 2026 · Pricing verified directly from provider sites and Trustpilot/BBB filings
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.
Pick TMates if:
You want compounded tirzepatide at a competitive flat rate ($167/mo on 12-month plan), you are an injectable user, and you want predictable flat pricing across all dose tiers as you titrate up.
See TMates PricingPick Strut Health if:
You are needle-averse and want an oral lozenge alternative, you place high value on pharmacy transparency (Strut owns its ACHC-accredited compounding pharmacy in-house), you want unlimited doctor access included, or you prefer month-to-month flexibility without an annual commitment.
See Strut Health PricingSide-by-Side Comparison
| Factor | TMates | Strut Health |
|---|---|---|
| Compounded Semaglutide | $158–$249/mo (flat across doses) | $199/mo (injectable or oral lozenge) |
| Compounded Tirzepatide | $167–$297/mo (flat across doses) | $199+/mo (limited availability, higher tier) |
| 503A Pharmacy | U.S. 503A (specific partner not publicly disclosed) | In-house ACHC-accredited compounding pharmacy |
| Trustpilot | 3.2/5 (low review volume) | ~3.5/5 (mixed reviews, BBB C- noted in some sources) |
| Cancel Policy | Cancel anytime, no contract | Cancel anytime, no membership fees |
| Pricing Model | Same flat price across all doses (rare in industry) | In-house pharmacy + oral lozenge format + unlimited doctor access |
Where Strut Health Beats TMates
- In-house ACHC-accredited compounding pharmacy — direct supply chain control vs TMates external 503A.
- Oral lozenge semaglutide format available for needle-averse users; TMates is injectable-only.
- Unlimited doctor access included; TMates uses async intake.
- Lower month-to-month pricing on semaglutide ($199 flat vs $249 TMates single-month).
Where TMates Beats Strut Health
- Strut tirzepatide availability is limited or premium-priced; TMates offers tirzepatide as a core product at $167/mo on annual plan.
- TMates 12-month plan ($158/mo) beats Strut Health $199/mo for users committing to a year.
- TMates has cleaner Trustpilot record on volume; Strut has mixed reviews and a noted BBB C- rating in some sources.
- TMates flat-dose pricing applies to all doses including high-tier; Strut Health does not match this.
Honest Take: Where TMates Falls Short
Strut Health owning its own ACHC-accredited compounding pharmacy is a real safety advantage that TMates does not match — direct chain-of-custody control over compounding reduces variability risk and quality concerns. For consumers who have read about FDA scrutiny of 503A compounding in 2026, this matters. TMates uses external 503A partners and does not publicly name them.
Red Flag to Know About Strut Health
Strut Health Trustpilot reviews are mixed and some sources list a BBB C- rating — verify current standing before signing up. Tirzepatide availability is limited; if tirzepatide is your goal, Strut may not be the right pick regardless of pharmacy transparency.
Related Guides
Continue your research with these related independent reviews.